SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-17-000255
Filing Date
2017-02-14
Accepted
2017-02-14 17:07:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 e615779_sc13ga-gtl.htm SC 13G/A 82611
  Complete submission text file 0001193805-17-000255.txt   84057
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Subject) CIK: 0001166272 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-87783 | Film No.: 17610311
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

IRS No.: 010786483 | State of Incorp.: DE
Type: SC 13G/A